| ZFIN ID: ZDB-EXP-160802-7 |
Experiment Conditions Description: chemical treatment: desferrioxamine B mesylate, chemical treatment: 5-aminolevulinic acid
| chemical treatment: desferrioxamine B mesylate |
|---|
| Name: | chemical treatment |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000111] |
| Name: | desferrioxamine B mesylate |
|---|---|
| Synonyms: | Deferoxamine B mesylate, Deferoxamine mesylate, Deferoxamine methanesulfonate, Desferal, Desferin, desferrioxamine B methanesulfonate, desferrioxamine mesilate, Desferrioxamine mesylate, Desferrioxamine methanesulfonate, N'-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate |
| Definition: | A methanesulfonate salt obtained by reaction of desferrioxamine B with one molar equivalent of methanesulfonic acid. It is an iron-chelating medicine used to remove excess iron from the body. It binds to iron in the blood, which is then passed out in the urine. |
| Ontology: | ChEBI [CHEBI:31460] ( EBI ) |
| chemical treatment: 5-aminolevulinic acid |
|---|
| Name: | chemical treatment |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the fish is treated with a chemical substance. This treatment could be administered by adding the chemical substance to the tank water, injections, or by consumption. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000111] |
| Name: | 5-aminolevulinic acid |
|---|---|
| Synonyms: | 5-ALA, 5-Amino-4-oxopentanoate, 5-amino-4-oxopentanoic acid, 5-Amino-4-oxovaleric acid, 5-Aminolevulinate, aminolevulinic acid, dALA, delta-ALA, delta-aminolevulinic acid |
| Definition: | The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. |
| Ontology: | ChEBI [CHEBI:17549] ( EBI ) |
| Publication: | Elenbaas et al., 2016 |
|---|